Balchem Corporation (BCPC)
BCPC Stock Price Chart
Explore Balchem Corporation interactive price chart. Choose custom timeframes to analyze BCPC price movements and trends.
BCPC Company Profile
Discover essential business fundamentals and corporate details for Balchem Corporation (BCPC) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Chemicals - Specialty
IPO Date
3 Jun 1986
Employees
1.38K
Website
https://www.balchem.comCEO
Theodore Lee Harris
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products. The Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, extrusion and agglomeration, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions for various applications; and human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. The Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production, and delivering nutrient supplements in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. This segment also markets and sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was incorporated in 1967 and is headquartered in New Hampton, New York.
BCPC Financial Timeline
Browse a chronological timeline of Balchem Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 22 Apr 2026
Upcoming earnings on 19 Feb 2026
Upcoming earnings on 24 Oct 2025
EPS estimate is $1.36, while revenue estimate is $258.28M.
Earnings released on 31 Jul 2025
EPS came in at $1.27 surpassing the estimated $1.25 by +1.60%, while revenue for the quarter reached $255.47M , missing expectations by -0.85%.
Earnings released on 24 Apr 2025
EPS came in at $1.22 falling short of the estimated $1.25 by -2.40%, while revenue for the quarter reached $250.52M , beating expectations by +1.96%.
Earnings released on 21 Feb 2025
EPS came in at $1.03 falling short of the estimated $1.11 by -7.21%, while revenue for the quarter reached $240.00M , missing expectations by -2.00%.
Dividend declared on 10 Dec 2024
A dividend of $0.87 per share was announced, adjusted to $0.87. The dividend was paid on 17 Jan 2025.
Earnings released on 25 Oct 2024
EPS came in at $1.13 surpassing the estimated $1.11 by +1.80%, while revenue for the quarter reached $239.94M , beating expectations by +2.07%.
Earnings released on 26 Jul 2024
EPS came in at $1.09 surpassing the estimated $1.03 by +5.83%, while revenue for the quarter reached $234.08M , missing expectations by -2.34%.
Earnings released on 3 May 2024
EPS came in at $1.03 surpassing the estimated $0.98 by +5.10%, while revenue for the quarter reached $239.66M , beating expectations by +3.10%.
Earnings released on 16 Feb 2024
EPS came in at $0.95 surpassing the estimated $0.93 by +2.15%, while revenue for the quarter reached $228.70M , missing expectations by -2.54%.
Dividend declared on 4 Dec 2023
A dividend of $0.79 per share was announced, adjusted to $0.79. The dividend was paid on 19 Jan 2024.
Earnings released on 27 Oct 2023
EPS came in at $1.04 surpassing the estimated $0.97 by +7.22%, while revenue for the quarter reached $229.95M , missing expectations by -3.01%.
Earnings released on 28 Jul 2023
EPS came in at $1.06 surpassing the estimated $0.84 by +26.19%, while revenue for the quarter reached $231.25M , missing expectations by -5.22%.
Earnings released on 28 Apr 2023
EPS came in at $0.70 falling short of the estimated $0.78 by -10.26%, while revenue for the quarter reached $232.54M , beating expectations by +0.31%.
Earnings released on 24 Feb 2023
EPS came in at $0.66 falling short of the estimated $0.90 by -26.67%, while revenue for the quarter reached $232.53M , missing expectations by -3.70%.
Dividend declared on 6 Dec 2022
A dividend of $0.71 per share was announced, adjusted to $0.71. The dividend was paid on 20 Jan 2023.
Earnings released on 4 Nov 2022
EPS came in at $1.00 surpassing the estimated $0.85 by +17.65%, while revenue for the quarter reached $244.27M , beating expectations by +1.94%.
Earnings released on 29 Jul 2022
EPS came in at $1.07 surpassing the estimated $0.91 by +17.58%, while revenue for the quarter reached $236.69M , beating expectations by +5.89%.
Earnings released on 29 Apr 2022
EPS came in at $1.03 surpassing the estimated $0.79 by +30.38%, while revenue for the quarter reached $228.87M , beating expectations by +10.19%.
Earnings released on 18 Feb 2022
EPS came in at $0.85 matching the estimated $0.85, while revenue for the quarter reached $213.13M , beating expectations by +7.55%.
Dividend declared on 16 Dec 2021
A dividend of $0.64 per share was announced, adjusted to $0.64. The dividend was paid on 21 Jan 2022.
Earnings released on 29 Oct 2021
EPS came in at $0.92 surpassing the estimated $0.90 by +2.22%, while revenue for the quarter reached $197.87M , beating expectations by +0.52%.
Earnings released on 30 Jul 2021
EPS came in at $0.93 surpassing the estimated $0.88 by +5.68%, while revenue for the quarter reached $202.37M , meeting expectations.
Earnings released on 30 Apr 2021
EPS came in at $0.87 surpassing the estimated $0.85 by +2.35%, while revenue for the quarter reached $185.66M , beating expectations by +2.34%.
Earnings released on 19 Feb 2021
EPS came in at $0.83 surpassing the estimated $0.81 by +2.47%, while revenue for the quarter reached $180.71M , beating expectations by +3.07%.
Dividend declared on 17 Dec 2020
A dividend of $0.58 per share was announced, adjusted to $0.58. The dividend was paid on 22 Jan 2021.
Earnings released on 28 Oct 2020
EPS came in at $0.83 surpassing the estimated $0.70 by +18.57%, while revenue for the quarter reached $175.14M , beating expectations by +18.57%.
BCPC Stock Performance
Access detailed BCPC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.